The rate of overdiagnosis inextricably linked to prostate-specific antigen-based screening for prostate cancer can be quantified in several ways, but what is the practicable message?

European Urology

Volumn 65, Issue 6, 2014, Pages 1056-1057

  Roobol, Monique J ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BREAST CANCER; CANCER SCREENING; DECISION MAKING; DIAGNOSTIC ERROR; EDITORIAL; ERECTILE DYSFUNCTION; HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RISK REDUCTION; URINARY DYSFUNCTION; BLOOD; EARLY DIAGNOSIS; MALE; PROSTATIC NEOPLASMS; UNNECESSARY PROCEDURE;

EARLY DETECTION OF CANCER; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UNNECESSARY PROCEDURES;

EID: 84899511464     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.01.016     Document Type: Editorial

References (10)

1. S. Loeb, M.A. Bjurlin, and J. Nicholson et al. Overdiagnosis and overtreatment of prostate cancer Eur Urol 65 2014 1046 1055
2. F.H. Schröder, J. Hugosson, and M.J. Roobol et al. Prostate-cancer mortality at 11 years of follow-up [published correction appears in N Engl J Med 2012;366:2137] N Engl J Med 366 2012 981 990
3. S. Loeb What is the true number needed to screen and treat to save a life with prostate specific antigen testing? J Clin Oncol 29 2011 464 467
4. J. Hugosson, S. Carlsson, and G. Aus et al. Mortality results from the Göteborg randomized population-based prostate-cancer screening trial Lancet Oncol 11 2010 725 732
5. K. Howard, A.T. Brenner, and Lewis et al. A comparison of US and Australian men's values and preferences for PSA screening BMC Health Services Research 13 2013 388
6. J. Hersch, J. Jansen, and A. Barratt et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study BMJ 346 2013 f158
7. E.W. De Bekker-Grob, J.M. Rose, and B. Donkers et al. Men's preferences for prostate cancer screening: a discrete choice experiment Br J Cancer 108 2013 533 541
8. I.J. Korfage, H.J. de Koning, and M.L. Essink-Bot Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study Qual Life Res 16 2007 1627 1634
9. M.J. Roobol, and S.V. Carlsson Risk stratification in prostate cancer screening Nat Rev Urol 10 2013 38 48
10. N.L. Robertson, M. Emberton, and C.M. Moore MRI-targeted prostate biopsy: a review of technique and results Nat Rev Urol 10 2013 589 597